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Crossing Barriers: infections of the lung and the gut 
 
Introduction 
Although known as respiratory pathogens, severe acute respiratory syndrome (SARS) 
and its sister coronaviruses frequently cause enteric symptoms. In addition, other 
classically non-enteric viruses (such as HIV and influenza) may also have enteric 
effects that are crucial in their pathogeneses. These effects can be due to direct 
infection of the gut mucosa, but can also be because of decreased antibacterial 
defences, increased mucosal permeability, bacterial translocation and systemic leak 
of endotoxin. 
 
Coronavirus colds and enteritis 
Molecular detection methods show that picornaviruses (rhinovirus and enterovirus) 
cause approximately 60% of common colds in older children and adults. The next 
most common are the coronaviruses, causing about 15% of colds. Human 
coronaviruses are classified genetically into three groups. One of the group 2 virus, 
OC43, shows remarkable antigenic and genetic similarities to a common bovine 
coronavirus that probably first mutated and transmitted to man in the 1890s 1. 
Although now transmitted from person to person via the respiratory tract, OC43 
causes gastrointestinal symptoms in up to 57% of infected people, along with various 
combinations of rhinitis (36.6%), pharyngitis (30%) and bronchitis or bronchiolitis 
(26.6%) 2. Therefore, gastrointestinal symptoms can be as prominent as respiratory 
symptoms in coronavirus colds, often labelled ‘gastric flu’. 
 
In veterinary practice, coronaviruses are also notorious for causing infection of either 
the gut or lung and for sometimes moving between sites. Porcine transmissible 
gastroenteritis virus (TGEV) is a coronavirus related to the 229E strain of coronavirus 
(another cause of common colds in man). TGEV was a major cause of severe 
gastroenteritis in domesticated pigs, causing significant morbidity and mortality 
throughout worldwide.  
 
However, in 1984 spontaneous deletions caused a new strain to emerge transmitted 
via the respiratory route and causing predominately upp r respiratory symptoms, and 
often mild or inapparent infection. This new virus was sufficiently antigenetically 
similar to TGEV to cause cross-protection 3, so that the new strain virtually wiped out 
the parental strain. Therefore, the respiratory version of the coronavirus acted as a 
natural vaccine, eliminating TGEV as a significant veterinary problem. 
 
SARS 
When SARS broke out in the winter of 2002/03, the world was gripped by a well-
founded fear that it would become a lethal pandemic. The acronym resonated with the 
public, helping to focus attention not only on the virus but also on its transmissibility 
and global potential. The original animal reservoir of the SARS coronavirus appears 
to be wild bats, although it probably adapted to infect nocturnal pine civet cats before 
moving in to man 4. Although SARS was dubbed ‘respiratory’, the virus was clearly 
not just a lung pathogen – it also affected the gut.  
 
The emerging epidemic came to the attention of virologists when it began to spread in 
Hong Kong in early March, 2002. One of the first major outbreaks was in a hospital, 
triggered by a ‘superspreading’ event following the admission of a doctor who had 
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acquired the infection while working with patients with atypical pneumonia in 
Guangdong Province of mainland China. In all, 70 hospital staff became infected in 
this one outbreak; this same index case apparently infected visitors to the hotel where 
the doctor stayed, one of whom flew to Hanoi, was admitted to hospital and there led 
to an outbreak in which 63 hospital staff were infected. Events in the same hotel 
probably led to the transmission of infection to Toronto, where a major outbreak also 
occurred. 
 
The major community transmission in Hong Kong occurred in a tower block complex 
named Amoy Gardens. In this case, the evidence points to transmission from soil 
pipes and sewage which appears to have led to aerosolisation of SARS coronavirus, 
and to inhalation and transmission to approximately 331 new individuals. This 
alarming ability to swop between being a respiratory and a gastrointestinal pathogen 
was one of the features made SARS so potentially devastating. 
 
SARS was characterised by intense systemic symptoms and triggering of exuberant 
host immune responses 5. Detailed pathological studies showed that SARS 
coronavirus could infect not only the respiratory epithelium, but also surface 
enterocytes in the small bowel. While infection caused diffuse alveolar damage, the 
changes in the gut are more subtle 6 and might include an increase in intestinal 
permeability to lipopolysaccharide (LPS) and transmigration of intestinal bacteria 
(Fig 1c).  
 
Remarkably, the onset of diarrhoea in SARS infected patients usually peaked on days 
4 to 9, by which time the fever had subsided. However, the coronavirus copy number 
in some studies showed an increase between day 5 and day 10, so that maximal 
infectivity followed the fever 7, leading perhaps to a false sense of security amongst 
those caring for SARS patients. While virus copy number in the pharyngeal aspirates 
dropped significantly between days 10 and 15, many patients still had SARS 
coronavirus present in the stool at day 21, by which time under 50% had virus present 
in the nasopharyngeal aspirate.  Therefore, late transmission by contact with stool was 
a particular unappreciated risk.  
 
Interactions between viruses and bacteria 
Infection with porcine respiratory coronavirus (PRCV) or porcine reproductive and 
respiratory syndrome virus (PRRSV) has a synergistic effect with bacterial products, 
demonstrated by enhanced inflammation induced by LPS from Escherichia coli. LPS 
caused potentiation of disease, with enhanced production of TNF, IL-1 and IL-6. 8. 
 
It has been known for many years that healthy people often carry pathogenic bacteria 
(such as Neisseria meningitides or Streptococcus pneumoniae) in the upper 
respiratory tract, but may only develop invasive disease during co-infection with 
respiratory viruses. The reason for these interactions are incompletely understood, but 
intriguing recent study show that influenza and RSV are both capable of causing a 
persistent inhibition of the innate response to bacterial superinfection, and therefore to 
increased bacterial replication and disease 9. 
 
Intestinal effects of HIV infection 
Although dual tropism for both the lung and gut may be an obvious and clear reason 
to consider the gut in respiratory infection, links can also be more subtle and complex. 
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Human immunodeficiency virus (HIV) targets CD4-expressing T-cells and 
macrophages, thereby leading to immunosuppression. However, the symptoms of 
progressive HIV infection sometimes include profound weight loss (“slim disease”), 
and evidence of systemic immune activation. Indeed, this immune activation may 
assist fresh infection by HIV of activated T cells, so enhancing the viral life cycle.  
 
The reasons for this immune activation seems to include the fact that HIV infects 
intestinal mucosal lymphocytes, including those in the Peyer’s patch and especially 
Th17 cells that normally keep bacteria in check 10 (Fig. 1b). This leads to enhanced 
gastrointestinal permeability to microbial products, causing increased levels of 
circulating lipopolysaccharide 11, further activating the innate and adaptive immune 
system. An additional intriguing possibility is that the distribution of FoxP3+ 
regulatory T cells is affected by HIV infection 12, and that the balance between pro-
inflammatory and antiviral effects is disturbed 13 thereby contributing to immune 
activation, malaise and cachexia in HIV infected patients.  
 
Intestinal infection by influenza 
Highly pathogenic strains of influenza also cause intense systemic symptoms, 
sometimes associated with gastrointestinal disease. In waterfowl, influenza is mostly 
an enteric pathogen, transmitted via the faeces in the lakes and waterways, and 
efficiently transmitted to other birds feeding and breeding on the same water. When 
these viruses spread to man, viral replication can trigger hypercytokinaemia 14.  
 
It therefore seems possible that the gut (known to be susceptible to infection with 
highly pathogenic strains of influenza 15) might also become permeable to intestinal 
lipopolysaccharide in severe influenza infections (Fig. 1c), or that bacterial 
translocation through the gut wall could contribute to systemic symptoms, cytokine 
release and circulatory collapse.  
 
Conclusions 
In the era of integrative systems biology and holistic medicine, it is not only timely 
but also essential to view the gut and the lung as a continuous surface with distinct but 
overlapping susceptibilities. In addition, viral and bacterial infections should not be 
regarded as isolated events but viewed both in the context of intercurrent infection 
and of previous infection history. Studies of single infections are certainly revealing, 
but in reality the secret to understanding variations in responses to infections must 
include an awareness of what else is present on a rich polymicrobial landscape. 
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Figure legend 
 
Alternative mechanisms of mucosal viral-bacterial interactions   
 
a: In the normal gut, intestinal flora are kept from invasion by the intact mucosa, even 
in the follicle-associated epithelium that specialises in transportation of antigen into 
the Peyer’s patch. b: if the submucosal lymphoid tissue is damaged by infection (e.g. 
with HIV 11), the mucosa becomes permeable to bacteria and to bacterial products. 
Translocation of bacteria and bacterial products from the intestinal lumen cause 
systemic innate stimulation, leading to malaise and other systemic symptoms. c: If a 
virus is tropic for the intestinal epithelial cells, it causes cell damage and loosens the 
normally impermeable barrier that keeps bacteria in the intestinal lumen.  
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